TY - JOUR T1 - Correlates of COVID-19 Vaccine Hesitancy among People who Inject Drugs in the San Diego-Tijuana Border Region JF - medRxiv DO - 10.1101/2021.10.29.21265669 SP - 2021.10.29.21265669 AU - Steffanie A. Strathdee AU - Daniela Abramovitz AU - Alicia Harvey-Vera AU - Carlos Vera AU - Gudelia Rangel AU - Irina Artamonova AU - Thomas L. Patterson AU - Rylie Mitchell AU - Angela R. Bazzi Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/10/30/2021.10.29.21265669.abstract N2 - Background People who inject drugs (PWID) are vulnerable to acquiring SARS-CoV-2 but their barriers to COVID-19 vaccination are under-studied. We examined correlates of COVID-19 vaccine hesitancy among PWID in the U.S.-Mexico border region, of whom only 7.6% had received ≥one COVID-19 vaccine dose by September, 2021.Methods Between October, 2020 and September, 2021, participants aged ≥18 years from San Diego, California, USA and Tijuana, Baja California, Mexico who injected drugs within the last month completed surveys and SARS-CoV-2, HIV, and HCV serologic testing. Logistic regressions with robust standard error estimation via generalized estimating equations identified factors associated with COVID-19 vaccine hesitancy, defined as being unsure or unwilling to receive COVID-19 vaccines.Results Of 393 participants, 127 (32.3%) were vaccine hesitant. Older participants, those with greater food insecurity, and those with greater concern about acquiring SARS-CoV-2 were more willing to be vaccinated. Higher numbers of chronic health conditions, having access to a smart phone or computer, and citing social media as one’s most important source of COVID-19 information were independently associated with vaccine hesitancy. COVID-19-related disinformation was independently associated with vaccine hesitancy (adjusted odds ratio: 1.51 per additional conspiracy theory endorsed; 95% confidence interval: 1.31-1.74).Conclusions Nearly one third of PWID in the San Diego-Tijuana border region reported COVID-19 vaccine hesitancy, which was significantly influenced by exposure to disinformation. Interventions that improve accurate knowledge and trust in COVID-19 vaccines are needed to increase vaccination in this vulnerable population.Summary Nearly one third of people who inject drugs in the U.S.-Mexico border region reported COVID-19 vaccine hesitancy, which was significantly influenced by exposure to disinformation and social media and inversely associated with food insecurity and high perceived threat of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) (R01DA049644-S1, R01DA049644-02S2, K01DA043412). Additional support was provided by the National Institute of Allergy and Infectious Diseases at NIH (P30 AI036214) and by the California HIV/AIDS Research Program (CHRP) (OS17-SD-001).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of University of California San Diego and the IRB of Universidad Xochicalco gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data used in this analysis is available after completion of the study in May 2022. Interested parties should contact Daniela Abramovitz at dabramovitz@health.ucsd.edu for more information on how to submit a data request. ER -